| Dermatitis |
1 |
1 |
| Toxicology |
0 |
0.57 |
| Geriatrics |
0 |
0.56 |
| Concerns of Elderly |
0 |
0.43 |
| Child |
0 |
0.39 |
| Genomic Medicine |
0 |
0.36 |
| Genetics |
0 |
0.33 |
| Pollutant |
0 |
0.33 |
| Serum Immunoglobulin E (IgE) |
0 |
0.33 |
| Atopic Dermatitis |
0 |
0.99 |
| Immunoglobulin E (IgE) |
0 |
0.29 |
| Washington |
0 |
0.28 |
| Washington DC |
0 |
0.24 |
| Sleep |
0 |
0.22 |
| Asthma |
0 |
0.2 |
| Sleep Disorders |
0 |
0.18 |
| Antihistamine |
0 |
0.17 |
| Cytokines |
0 |
0.17 |
| Eosinophils |
0 |
0.17 |
| Trunk |
0 |
0.17 |
| UK Site Content |
0 |
0.17 |
| Patient Safety |
0 |
0.12 |
| Adverse Effects |
0 |
0.11 |
| Birth |
0 |
0.11 |
| Eczema |
0 |
0.11 |
| Meta-Analysis |
0 |
0.11 |
| Primary Care |
0 |
0.11 |
| Sedative |
0 |
0.11 |
| Thymus |
0 |
0.11 |
| Circadian Rhythm |
0 |
0.1 |
| Adolescent Medicine |
0 |
0.06 |
| Allergens |
0 |
0.06 |
| Biologic Therapy |
0 |
0.06 |
| Biomarker |
0 |
0.06 |
| Biopsy |
0 |
0.06 |
| Board Certification |
0 |
0.06 |
| Caregiver |
0 |
0.06 |
| Chemokines |
0 |
0.06 |
| Clinical Research |
0 |
0.06 |
| Dementia |
0 |
0.06 |
| Healthcare and Medical Technology |
0 |
0.06 |
| Illinois |
0 |
0.06 |
| Immunoglobulin A (IgA) |
0 |
0.06 |
| Interleukin |
0 |
0.06 |
| Mobility |
0 |
0.06 |
| Residency |
0 |
0.06 |
| Smoking |
0 |
0.06 |
| Social Determinants of Health |
0 |
0.06 |
| Socioeconomics |
0 |
0.06 |
| Tobacco Cessation |
0 |
0.06 |